387 related articles for article (PubMed ID: 19744599)
1. Nephrogenic systemic fibrosis: histology and gadolinium detection.
Thakral C; Abraham JL
Radiol Clin North Am; 2009 Sep; 47(5):841-53, vi-vii. PubMed ID: 19744599
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
Thakral C; Abraham JL
J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
[TBL] [Abstract][Full Text] [Related]
3. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
Boyd AS; Sanyal S; Abraham JL
J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
[TBL] [Abstract][Full Text] [Related]
4. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
Wiedemeyer K; Kutzner H; Abraham JL; Thakral C; Carlson JA; Tran TA; Hausser I; Hartschuh W
Am J Dermatopathol; 2009 Oct; 31(7):674-81. PubMed ID: 19633532
[TBL] [Abstract][Full Text] [Related]
5. Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of gadolinium deposits in skin.
Thakral C; Abraham JL
J Electron Microsc (Tokyo); 2007 Oct; 56(5):181-7. PubMed ID: 17951398
[TBL] [Abstract][Full Text] [Related]
6. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.
Sanyal S; Marckmann P; Scherer S; Abraham JL
Nephrol Dial Transplant; 2011 Nov; 26(11):3616-26. PubMed ID: 21441397
[TBL] [Abstract][Full Text] [Related]
7. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
[TBL] [Abstract][Full Text] [Related]
8. [Nephrogenic systemic fibrosis--new clinical entity].
Prvulović M
Med Pregl; 2008; 61(9-10):439-41. PubMed ID: 19203058
[TBL] [Abstract][Full Text] [Related]
9. The role of residual gadolinium in the induction of nephrogenic systemic fibrosis-like skin lesions in rats.
Pietsch H; Raschke M; Ellinger-Ziegelbauer H; Jost G; Walter J; Frenzel T; Lenhard D; Hütter J; Sieber MA
Invest Radiol; 2011 Jan; 46(1):48-56. PubMed ID: 20938346
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis: clinical picture and treatment.
Marckmann P; Skov L
Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
[TBL] [Abstract][Full Text] [Related]
11. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
Wilford C; Fine JD; Boyd AS; Sanyal S; Abraham JL; Kantrow SM
Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure.
Schäd SG; Heitland P; Kühn-Velten WN; Gross GE; Jonas L
J Cutan Pathol; 2013 Nov; 40(11):935-44. PubMed ID: 24102613
[TBL] [Abstract][Full Text] [Related]
13. [Nephrogenic systemic fibrosis and use of MR contrast media].
Christiansen RE; Sviland L; Sekse I; Svarstad E
Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
[TBL] [Abstract][Full Text] [Related]
14. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
Abraham JL; Thakral C; Skov L; Rossen K; Marckmann P
Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic systemic fibrosis.
Weinreb JC; Kuo PH
Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
Weinreb JC; Abu-Alfa AK
J Magn Reson Imaging; 2009 Dec; 30(6):1236-9. PubMed ID: 19938035
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Broome DR
Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Kay J
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
[TBL] [Abstract][Full Text] [Related]
19. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
Grant D; Johnsen H; Juelsrud A; Løvhaug D
Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis: history and epidemiology.
Thomsen HS
Radiol Clin North Am; 2009 Sep; 47(5):827-31, vi. PubMed ID: 19744597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
